-
How the Paternal Brain Is Wired by Pregnancy. JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-13 Hugo Bottemanne,Lucie Joly
-
Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-13 Markku Lähteenvuo, Jari Tiihonen, Anssi Solismaa, Antti Tanskanen, Ellenor Mittendorfer-Rutz, Heidi Taipale
ImportancePreliminary studies suggest that glucagon-like peptide-1 receptor (GLP-1) agonists, used to treat type 2 diabetes and obesity, may decrease alcohol consumption.ObjectiveTo test whether the risk of hospitalization due to alcohol use disorder (AUD) is decreased during the use of GLP-1 agonists compared with periods of nonuse for the same individual.Design, Setting, and ParticipantsThis cohort
-
Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-13 Daniel T. Myran, Michael Pugliese, Jennifer Xiao, Tyler S. Kaster, M. Ishrat Husain, Kelly K. Anderson, Nicholas Fabiano, Stanley Wong, Jess G. Fiedorowicz, Colleen Webber, Peter Tanuseputro, Marco Solmi
ImportanceInterest in and use of hallucinogens has been increasing rapidly. While a frequently raised concern is that hallucinogens may be associated with an increased risk of psychosis, there are limited data on this association.ObjectivesTo examine whether individuals with an emergency department (ED) visit involving hallucinogen use have an increased risk of developing a schizophrenia spectrum disorder
-
Grief-Specific Cognitive Behavioral Therapy vs Present-Centered Therapy JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-13 Rita Rosner, Jörn Rau, Anette Kersting, Winfried Rief, Regina Steil, Anna-Maria Rummel, Anna Vogel, Hannah Comtesse
ImportanceProlonged grief disorder (PGD) is included as a new diagnosis in international classification systems. Treatments following a cognitive behavioral model are most effective, but comparisons with active control treatments are scarce.ObjectiveTo examine whether integrative cognitive behavioral therapy for prolonged grief (PG-CBT) is superior to present-centered therapy (PCT).Design, Setting
-
Synaptic Density in Early Stages of Psychosis and Clinical High Risk JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-13 M. Belen Blasco, Kankana Nisha Aji, Christian Ramos-Jiménez, Ilana Ruth Leppert, Christine Lucas Tardif, Johan Cohen, Pablo M. Rusjan, Romina Mizrahi
ImportanceSynaptic dysfunction is involved in schizophrenia pathophysiology. However, whether in vivo synaptic density is reduced in early stages of psychosis, including its high-risk states, remains unclear.ObjectiveTo investigate whether synaptic density (synaptic vesicle glycoprotein 2A [SV2A] binding potential) is reduced in first-episode psychosis (FEP) and in clinical high risk (CHR) and investigate
-
Neuroinflammation, Stress-Related Suicidal Ideation, and Negative Mood in Depression JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-06 Sarah Herzog, Elizabeth A. Bartlett, Francesca Zanderigo, Hanga C. Galfalvy, Ainsley Burke, Akiva Mintz, Mike Schmidt, Eric Hauser, Yung-yu Huang, Nadine Melhem, M. Elizabeth Sublette, Jeffrey M. Miller, J. John Mann
ImportanceBrain translocator protein 18k Da (TSPO) binding, a putative marker of neuroinflammatory processes (eg, gliosis), is associated with stress and elevated in depressed and suicidal populations. However, it is unclear whether neuroinflammation moderates the impact of daily life stress on suicidal ideation and negative affect, thereby increasing risk for suicidal behavior.ObjectiveTo examine
-
Psychosis Spectrum Symptoms Before and After Adolescent Cannabis Use Initiation JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-06 K. Juston Osborne, Deanna M. Barch, Joshua J. Jackson, Nicole R. Karcher
ImportanceAdolescent cannabis use has been consistently posited to contribute to the onset and progression of psychosis. However, alternative causal models may account for observed associations between cannabis use and psychosis risk, including shared vulnerability for both cannabis use and psychosis or efforts to self-medicate distress from psychosis spectrum symptomology.ObjectiveTo test 3 hypotheses
-
Racial and Ethnic Disparities in Fentanyl and Polysubstance Overdose Deaths JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-06 David T. Zhu
This cross-sectional study describes US overdose death patterns for fentanyl and fentanyl combined with opioids, heroin, cocaine, methamphetamine, or benzodiazepines by race and ethnicity from 2010 to 2022.
-
TikTok Challenges—Unintentional Injuries vs Suicide Attempts JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-06 Onomeasike Ataga, Valerie K. Arnold
This Viewpoint discusses injuries among US children that are attributable to TikTok challenges, addresses the challenge of distinguishing between unintentional injuries and suicide attempts, and explores potential methods of prevention, treatment, and clinical disposition for such injuries.
-
Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical Trial. JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-30 Tarek K Rajji,Christopher R Bowie,Nathan Herrmann,Bruce G Pollock,Krista L Lanctôt,Sanjeev Kumar,Alastair J Flint,Linda Mah,Corinne E Fischer,Meryl A Butters,Marom Bikson,James L Kennedy,Daniel M Blumberger,Zafiris J Daskalakis,Damien Gallagher,Mark J Rapoport,Nicolaas P L G Paul Verhoeff,Angela C Golas,Ariel Graff-Guerrero,Erica Vieira,Aristotle N Voineskos,Heather Brooks,Ashley Melichercik,Kevin
Importance Older adults with major depressive disorder (MDD) or mild cognitive impairment (MCI) are at high risk for cognitive decline. Objective To assess the efficacy of cognitive remediation (CR) plus transcranial direct current stimulation (tDCS) targeting the prefrontal cortex in slowing cognitive decline, acutely improving cognition, and reducing progression to MCI or dementia in older adults
-
Depression Diagnosis, Treatment, and Remission Among Adults in India JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-30 Felix Teufel, Aastha Aggarwal, Lydia Chwastiak, Vikram Patel, Mohammed K. Ali
ImportanceDepression is a leading contributor to mental health burdens globally and in India, the world’s most populous country. National-level evidence on health coverage for adults with depression in India is lacking.ObjectiveTo estimate proportions of middle-aged and older adults with depression in India who used health care services, were diagnosed with depression, received treatment, and were
-
Sexual Trauma, Polygenic Scores, and Mental Health Diagnoses and Outcomes JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-30 Allison M. Lake, Yu Zhou, Bo Wang, Ky’Era V. Actkins, Yingzhe Zhang, John P. Shelley, Anindita Rajamani, Michael Steigman, Chris J. Kennedy, Jordan W. Smoller, Karmel W. Choi, Nikhil K. Khankari, Lea K. Davis
ImportanceLeveraging real-world clinical biobanks to investigate the associations between genetic and environmental risk factors for mental illness may help direct clinical screening efforts and evaluate the portability of polygenic scores across environmental contexts.ObjectiveTo examine the associations between sexual trauma, polygenic liability to mental health outcomes, and clinical diagnoses of
-
Posttraumatic Stress Disorder, Obesity, and Accelerated Epigenetic Aging Among US Military Veterans JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-30 Ian C. Fischer, Peter J. Na, Sheila T. Nagamatsu, Dilip V. Jeste, Brenda Cabrera-Mendoza, Janitza L. Montalvo-Ortiz, John H. Krystal, Renato Polimanti, Joel Gelernter, Robert H. Pietrzak
This cross-sectional study uses data from 1135 male, European-American US military veterans to assess whether risk and protective factors influenced associations between posttraumatic stress disorder and epigenetic age.
-
Traumatic and Adverse Childhood Experiences and Developmental Differences in Psychiatric Risk JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-23 Justin D. Russell, Sara A. Heyn, Matthew Peverill, Samantha DiMaio, Ryan J. Herringa
ImportanceWhile adverse childhood experiences (ACEs) are known to impart significant risk for negative mental health and cognitive outcomes in youth, translation of ACE scores into clinical intervention is limited by poor specificity in predicting negative outcomes. This work expands on the ACE framework using a data-driven approach to identify 8 different forms of traumatic and adverse childhood experiences
-
Diagnosing and Treating ADHD in Adults JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-23 Carlos Blanco, Craig B. H. Surman
This Viewpoint advocates for proactively addressing concerns related to the diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD) in US adults to balance individual benefits with population-level risk.
-
Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk. JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-23 Yuki Kikuchi,Hiroshi Komatsu,Hiroaki Tomita
-
Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-23 Jurjen J Luykx,Jari Tiihonen,Heidi Taipale
-
Development of Sensory Regions vs the Rest of the Cortex in Autism. JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-16 Jessica Girault
-
Toward Equitable Interventions in Public Mental Health JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-16 Ulrich Reininghaus, Annika S. Reinhold, Stefan Priebe, Christian Rauschenberg, Leonie Fleck, Anita Schick, Frederike Schirmbeck, Inez Myin-Germeys, Craig Morgan, Jessica A. Hartmann
ImportanceThe field of public mental health is evolving to tackle the profound impact of global challenges such as climate change, migration, and health crises. These issues accentuate health and social inequities, necessitating a focus on how to achieve interventions that are equitable and enhance mental health across all societal strata.ObservationsPopulation-based interventions can inadvertently
-
Antipsychotic Drugs and Cognitive Function JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-16 Lena Feber, Natalie L. Peter, Virginia Chiocchia, Johannes Schneider-Thoma, Spyridon Siafis, Irene Bighelli, Wulf-Peter Hansen, Xiao Lin, Daniel Prates-Baldez, Georgia Salanti, Richard S. E. Keefe, Rolf R. Engel, Stefan Leucht
ImportanceCognitive deficits are a substantial part of the symptoms of schizophrenia spectrum disorders (SSDs) and contribute heavily to the burden of disease. Antipsychotic drugs are not cognitive enhancers, but due to their different receptor-binding profiles, they could differ in their effects on cognition. No previous network meta-analysis compared antipsychotics to placebo, which is important
-
Patterns of Brain Maturation in Autism and Their Molecular Associations. JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-16 Charlotte M Pretzsch,Martina Arenella,Jason P Lerch,Michael V Lombardo,Christian Beckmann,Tim Schaefer,Johanna Leyhausen,Caroline Gurr,Anke Bletsch,Lisa M Berg,Hanna Seelemeyer,Dorothea L Floris,Bethany Oakley,Eva Loth,Thomas Bourgeron,Tony Charman,Jan Buitelaar,Grainne McAlonan,Declan Murphy,Christine Ecker,
Importance In the neurotypical brain, regions develop in coordinated patterns, providing a fundamental scaffold for brain function and behavior. Whether altered patterns contribute to clinical profiles in neurodevelopmental conditions, including autism, remains unclear. Objectives To examine if, in autism, brain regions develop differently in relation to each other and how these differences are associated
-
Addressing the Escalating Problems That Patients Encounter When Filling Buprenorphine Prescriptions JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-16 Erin L. Winstanley, Angela Gray, Douglas Thornton
This Viewpoint describes both the current barriers patients face when filling their prescriptions for buprenorphine at pharmacies and a list of proposed fixes requiring changes at the federal, state, insurance, and clinician level.
-
An Architecture for Transformation in Child Mental Health JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-09 John N. Constantino, Laura J. Dilly
This Viewpoint describes efforts to provide timely, comprehensive, and high-quality mental health care to a large population-representative subset of children within a single health system and demonstrate its potential impact and true cost.
-
Deconstructing Cognitive Impairment in Psychosis With a Machine Learning Approach JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-09 Robert A. McCutcheon, Richard S. E. Keefe, Philip M. McGuire, Andre Marquand
ImportanceCognitive functioning is associated with various factors, such as age, sex, education, and childhood adversity, and is impaired in people with psychosis. In addition to specific effects of the disorder, cognitive impairments may reflect a greater exposure to general risk factors for poor cognition.ObjectiveTo determine the extent that impairments in cognition in psychosis reflect risk factor
-
Informant Effect on Placebo Response in Mental Disorders-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-01 Tom Bschor,Christopher Baethge
-
Informant Effect on Placebo Response in Mental Disorders. JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-01 Toshi A Furukawa,Pim Cuijpers
-
Informant Effect on Placebo Response in Mental Disorders. JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-01 Natan Pereira Gosmann,Giovanni Abrahão Salum
-
The Psychotherapy in MDMA-Assisted Psychotherapy JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-02 Ioana Alina Cristea, Pim Cuijpers, Joar Øveraas Halvorsen
This Viewpoint discusses the critical yet overlooked role of the psychotherapy component in assessing the validity of the trials of midomafetamine/3,4-methylenedioxymethamphetamine (MDMA)–assisted psychotherapy for posttraumatic stress disorder.
-
A Group Parenting Intervention for Male Postpartum Depression JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-02 M. Ishrat Husain, Tayyeba Kiran, Rabia Sattar, Ameer B. Khoso, Ming Wai Wan, Daisy R. Singla, Madeha Umer, Rabdino Mangrio, Paul Bassett, Imran B. Chaudhry, Shehla N. Zafar, Farhat A. Jafri, Nasim Chaudhry, Nusrat Husain
ImportanceMale postpartum depression is prevalent across populations; however, there is limited evidence on strategies to address it, particularly in low-income settings.ObjectiveTo evaluate the effectiveness of Learning Through Play Plus Dads (LTP + Dads), a nonspecialist–delivered psychosocial intervention, in improving symptoms of male postpartum depression compared to treatment as usual.Design
-
Bright Light Therapy for Nonseasonal Depressive Disorders JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-02 Artur Menegaz de Almeida, Francisco Cezar Aquino de Moraes, Maria Eduarda Cavalcanti Souza, Jorge Henrique Cavalcanti Orestes Cardoso, Fernanda Tamashiro, Celso Miranda, Lilianne Fernandes, Michele Kreuz, Francinny Alves Kelly
ImportanceSeasonal humor disorders are prone to have a link with daylight exposure. However, the effect of external light on nonseasonal disorders remains unclear. Evidence is lacking for the validity of bright light therapy (BLT) as an adjunctive treatment for these patients.ObjectiveTo assess BLT effectiveness as an adjunctive treatment for nonseasonal depressive disorders.Data SourcesIn March 2024
-
Suicidal Ideation and Suicide Attempts After Direct or Indirect Psychotherapy JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-25 Wouter van Ballegooijen, Josine Rawee, Christina Palantza, Clara Miguel, Mathias Harrer, Ioana Cristea, Remco de Winter, Renske Gilissen, Merijn Eikelenboom, Aartjan Beekman, Pim Cuijpers
ImportanceSuicidal ideation and suicide attempts are debilitating mental health problems that are often treated with indirect psychotherapy (ie, psychotherapy that focuses on other mental health problems, such as depression or personality disorders). The effects of direct and indirect psychotherapy on suicidal ideation have not yet been examined in a meta-analysis, and several trials have been published
-
Actualizing Military Suicide Prevention Through Digital Health Modernization. JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-25 Ian H Stanley,Ellen P Embrey,Vikhyat S Bebarta
-
Predicting Suicides Among US Army Soldiers After Leaving Active Service JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-25 Chris J. Kennedy, Jaclyn C. Kearns, Joseph C. Geraci, Sarah M. Gildea, Irving H. Hwang, Andrew J. King, Howard Liu, Alex Luedtke, Brian P. Marx, Santiago Papini, Maria V. Petukhova, Nancy A. Sampson, Jordan W. Smoller, Charles J. Wolock, Nur Hani Zainal, Murray B. Stein, Robert J. Ursano, James R. Wagner, Ronald C. Kessler
ImportanceThe suicide rate of military servicemembers increases sharply after returning to civilian life. Identifying high-risk servicemembers before they leave service could help target preventive interventions.ObjectiveTo develop a model based on administrative data for regular US Army soldiers that can predict suicides 1 to 120 months after leaving active service.Design, Setting, and ParticipantsIn
-
Are Psychiatric Nosologies Limiting the Success of Clinical Prediction Models? JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-01 Isabelle Scott,Barnaby Nelson
-
Patient Self-Guided Interventions to Reduce Sedative Use and Improve Sleep JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-18 David M. Gardner, Justin P. Turner, Sandra Magalhaes, Malgorzata Rajda, Andrea L. Murphy
ImportanceDirect-to-patient interventions enabling transitions from long-term benzodiazepine receptor agonist (BZRA) use to cognitive behavioral therapy for insomnia (CBTI) by older adults has the potential to reduce BZRA use and related harms while improving sleep outcomes without requiring prearranged clinician involvement.ObjectiveTo compare 2 direct-to-patient behavior change interventions with
-
Suicidality Calls to a National Helpline After a Terror Attack and War JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-18 Joy Benatov, Liat Itzhaky, Shiri Daniels, Gil Zalsman
ImportanceChanges in suicide rates after a nationwide trauma may be different from changes in psychiatric symptoms or general distress after such events. However, very few studies have examined short-term suicide-related reactions after such an event.ObjectiveTo evaluate the short-term outcome of the events in Israel on October 7, 2023, a large-scale terror attack and unfolding war, on changes in suicidality
-
Clinical Outcomes of Continuation and Maintenance Electroconvulsive Therapy JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-18 Anders Jørgensen, Frederikke Hoerdam Gronemann, Maarten P. Rozing, Martin B. Jørgensen, Merete Osler
ImportanceLarge-scale evidence for the efficacy of continuation and maintenance electroconvulsive therapy (c/mECT) is lacking.ObjectiveTo provide an exhaustive and naturalistic insight into the real-world outcomes and the cost-effectiveness of c/mECT in a large dataset.Design, Setting, and ParticipantsThis cohort study included all patients in the Danish National Patient Registry who initiated treatment
-
Brief Cognitive Behavioral Therapy for Suicidal Inpatients JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-11 Gretchen J. Diefenbach, Kayla A. Lord, Jessica Stubbing, M. David Rudd, Hannah C. Levy, Blaise Worden, Kimberly S. Sain, Jessica G. Bimstein, Tyler B. Rice, Kate Everhardt, Ralitza Gueorguieva, David F. Tolin
ImportanceSuicide risk is elevated after discharge from inpatient level of care. Empirically supported inpatient suicide prevention treatments are needed.ObjectiveTo determine whether adding an inpatient version of brief cognitive behavioral therapy for suicide prevention to treatment as usual reduces postdischarge suicide attempts, suicidal ideation, and psychiatric readmissions and to determine whether
-
Amygdala Reactivity, Antidepressant Discontinuation, and Relapse JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-11 Tore Erdmann, Isabel M. Berwian, Klaas Enno Stephan, Erich Seifritz, Henrik Walter, Quentin J. M. Huys
ImportanceAntidepressant discontinuation substantially increases the risk of a depression relapse, but the neurobiological mechanisms through which this happens are not known. Amygdala reactivity to negative information is a marker of negative affective processes in depression that is reduced by antidepressant medication, but it is unknown whether amygdala reactivity is sensitive to antidepressant
-
Deconstructing the Construction of Value in Anorexia Nervosa JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-11 E. Caitlin Lloyd, Joanna E. Steinglass, Karin E. Foerde
This Viewpoint describes the importance of understanding the neurocomputational mechanisms by which individuals with anorexia nervosa assign value to food.
-
Prioritization of Psychopathological Symptoms and Clinical Characterization in Psychiatric Diagnoses JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-11 Stefan Leucht, Jim van Os, Markus Jäger, John M. Davis
ImportancePsychiatry mainly deals with conditions that are mediated by brain function but are not directly attributable to specific brain abnormalities. Given the lack of concrete biological markers, such as laboratory tests or imaging results, the development of diagnostic systems is difficult.ObservationsThis narrative review evaluated 9 diagnostic approaches. The validity of the DSM and the International
-
Commercial Interests and EEG Data Collection. JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-01 Dost Ongur
-
Bringing Imaging Biomarkers Into Clinical Reality in Psychiatry JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-04 Amit Etkin, Daniel H. Mathalon
ImportanceAdvancing precision psychiatry, where treatments are based on an individual’s biology rather than solely their clinical presentation, requires attention to several key attributes for any candidate biomarker. These include test-retest reliability, sensitivity to relevant neurophysiology, cost-effectiveness, and scalability. Unfortunately, these issues have not been systematically addressed
-
Risk of Suicide Across Medical Conditions and the Role of Prior Mental Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-04 Søren Dinesen Østergaard, Natalie C. Momen, Uffe Heide-Jørgensen, Oleguer Plana-Ripoll
ImportanceAccording to the World Health Organization, more than 700 000 individuals worldwide die by suicide each year. Medical conditions likely increase the risk of suicide.ObjectiveTo (1) provide age- and sex-specific pairwise estimates of the risk of suicide across a comprehensive range of medical conditions, (2) investigate whether there is a dose-response–like relationship at play (ie, the higher
-
Adverse Events in Studies of Classic Psychedelics JAMA Psychiatry (IF 22.5) Pub Date : 2024-09-04 Jared T. Hinkle, Marianna Graziosi, Sandeep M. Nayak, David B. Yaden
ImportanceA clear and comprehensive understanding of risks associated with psychedelic-assisted therapy is necessary as investigators extend its application to new populations and indications.ObjectiveTo assess adverse events (AEs) associated with classic psychedelics, particularly serious AEs (SAEs) and nonserious AEs (NSAEs) requiring medical or psychiatric evaluation.Data SourcesThe search for potentially
-
Psychiatric Symptoms, Cognition, and Symptom Severity in Children JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-28 Adam Pines, Leonardo Tozzi, Claire Bertrand, Arielle S. Keller, Xue Zhang, Susan Whitfield-Gabrieli, Trevor Hastie, Bart Larsen, John Leikauf, Leanne M. Williams
ImportanceMental illnesses are a leading cause of disability globally, and functional disability is often in part caused by cognitive impairments across psychiatric disorders. However, studies have consistently reported seemingly opposite findings regarding the association between cognition and psychiatric symptoms.ObjectiveTo determine if the association between general cognition and mental health
-
Polygenic Risk Scores and Twin Concordance for Schizophrenia and Bipolar Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-28 Jie Song, Joëlle A. Pasman, Viktoria Johansson, Ralf Kuja-Halkola, Arvid Harder, Robert Karlsson, Yi Lu, Kaarina Kowalec, Nancy L. Pedersen, Tyrone D. Cannon, Christina M. Hultman, Patrick F. Sullivan
ImportanceSchizophrenia and bipolar disorder are highly heritable psychiatric disorders with strong genetic and phenotypic overlap. Twin and molecular methods can be leveraged to predict the shared genetic liability to these disorders.ObjectiveTo investigate whether twin concordance for psychosis depends on the level of polygenic risk score (PRS) for psychosis and zygosity and compare PRS from cases
-
COVID-19 and Mental Illnesses in Vaccinated and Unvaccinated People. JAMA Psychiatry (IF 22.5) Pub Date : 2024-11-01 Venexia M Walker,Praveetha Patalay,Jose Ignacio Cuitun Coronado,Rachel Denholm,Harriet Forbes,Jean Stafford,Bettina Moltrecht,Tom Palmer,Alex Walker,Ellen J Thompson,Kurt Taylor,Genevieve Cezard,Elsie M F Horne,Yinghui Wei,Marwa Al Arab,Rochelle Knight,Louis Fisher,Jon Massey,Simon Davy,Amir Mehrkar,Seb Bacon,Ben Goldacre,Angela Wood,Nishi Chaturvedi,John Macleod,Ann John,Jonathan A C Sterne,
Importance Associations have been found between COVID-19 and subsequent mental illness in both hospital- and population-based studies. However, evidence regarding which mental illnesses are associated with COVID-19 by vaccination status in these populations is limited. Objective To determine which mental illnesses are associated with diagnosed COVID-19 by vaccination status in both hospitalized patients
-
Trajectories of Inflammation in Youth and Risk of Mental and Cardiometabolic Disorders in Adulthood JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-21 Edward R. Palmer, Isabel Morales-Muñoz, Benjamin I. Perry, Steven Marwaha, Ella Warwick, Jack C. Rogers, Rachel Upthegrove
ImportanceResearch suggests that low-grade, nonresolving inflammation may predate adult mental and physical illness. However, evidence to date is largely cross-sectional or focuses on single disorder outcomes.ObjectivesTo examine trajectories of inflammation as measured by C-reactive protein (CRP) levels in a large sample of children and adolescents, and to explore associations between different identified
-
Inflammatory Biomarkers and Risk of Psychiatric Disorders JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-21 Yu Zeng, Charilaos Chourpiliadis, Niklas Hammar, Christina Seitz, Unnur A. Valdimarsdóttir, Fang Fang, Huan Song, Dang Wei
ImportanceIndividuals with psychiatric disorders have been reported to have elevated levels of inflammatory biomarkers, and prospective evidence is limited regarding the association between inflammatory biomarkers and subsequent psychiatric disorders risk.ObjectiveTo assess the associations between inflammation biomarkers and subsequent psychiatric disorders risk.Design, Setting, and ParticipantsThis
-
Semaglutide in Psychiatry—Opportunities and Challenges JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-21 Sri Mahavir Agarwal, Margaret Hahn
This Viewpoint discusses clinical trial results of glucagon-like peptide 1 receptor agonists for treating the weight gain and cardiovascular disease risk of psychiatric medications.
-
Mental Health Diagnoses in People Experiencing Homelessness-Reply. JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-01 Rebecca Barry,Dallas Seitz
-
Mental Health Diagnoses in People Experiencing Homelessness. JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-01 Kevin Y Xu,Sonya E Gabrielian,Tashalee R Brown
-
Mental Health Care Support in Rural India JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-14 Pallab K. Maulik, Mercian Daniel, Siddhardha Devarapalli, Sudha Kallakuri, Amanpreet Kaur, Arpita Ghosh, Laurent Billot, Ankita Mukherjee, Rajesh Sagar, Sashi Kant, Susmita Chatterjee, Beverley M. Essue, Usha Raman, Devarsetty Praveen, Graham Thornicroft, Shekhar Saxena, Anushka Patel, David Peiris
ImportanceMore than 150 million people in India need mental health care but few have access to affordable care, especially in rural areas.ObjectiveTo determine whether a multifaceted intervention involving a digital health care model along with a community-based antistigma campaign leads to reduced depression risk and lower mental health–related stigma among adults residing in rural India.Design, Setting
-
Hyperalgesia in Patients With a History of Opioid Use Disorder JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-14 Martin Trøstheim, Marie Eikemo
ImportanceShort-term and long-term opioid treatment have been associated with increased pain sensitivity (ie, opioid-induced hyperalgesia). Treatment of opioid use disorder (OUD) mainly involves maintenance with methadone and buprenorphine, and observations of heightened cold pain sensitivity among patients are often considered evidence of opioid-induced hyperalgesia.ObjectiveTo critically examine
-
Training Psychiatrist-Scientists-Excellence on Both Sides of the Hyphen. JAMA Psychiatry (IF 22.5) Pub Date : 2024-10-01 Jacob L Taylor,James B Potash
-
Unveiling the Structure in Mental Disorder Presentations JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-07 Tobias R. Spiller, Or Duek, Markus Helmer, John D. Murray, Elliot Fielstein, Robert H. Pietrzak, Roland von Känel, Ilan Harpaz-Rotem
ImportanceDSM criteria are polythetic, allowing for heterogeneity of symptoms among individuals with the same disorder. In empirical research, most combinations were not found or only rarely found, prompting criticism of this heterogeneity.ObjectiveTo elaborate how symptom-based definitions and assessments contribute to a distinct probability pattern for the occurrence of symptom combinations.Design
-
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-07 Gil Grunfeld, Ann-Catherine Lemonde, Ian Gold, Vincent Paquin, Srividya N. Iyer, Martin Lepage, Ridha Joober, Ashok Malla, Jai L. Shah
ImportanceDespite growing interest in the phenomenology of delusions in psychosis, at present little is known about their content and evolution over time, including whether delusion themes are consistent across episodes.ObjectiveTo examine the course of delusions and thematic delusion content across relapse episodes in patients presenting to an early intervention service for psychosis.Design, Setting
-
-
Roles That Psychiatrists Can Play in International Negotiations to Reduce Conflict. JAMA Psychiatry (IF 22.5) Pub Date : 2024-08-01 Neil Krishan Aggarwal